ITRE - Presentation of the Belgian Presidency's priorities

CCC meeting - Exchange of views with David O’SULLIVAN, International Special Envoy for the Implementation of EU Sanctions

CCC meeting

EP Plenary session - European Health Data Space

EP Plenary session - Framework for ensuring a secure and sustainable supply of critical raw materials

COP28 UAE - United Nations Climate Change Conference

ITRE committee meeting

Plenary session - Neighbourhood, Development and International Cooperation

EURANET Citizen's corner - Radio debate

Plenary session in Brussels - Week 05  2017Democracy and Justice in Romania

Martin SCHULZ - EP President, Nicolas SCHMIT Minister of Labour, Employment and the Social and Solidarity Economy, Cristian-Silviu BUSOI

EP President at the Lex signing

Richard SULLIVAN, Francesco de LORENZO, Elisabetta GARDINI, Mark LAWYER, Cristian-Silviu BUSOI, Francesco PERRONE, Vlad VOICULESCU

EPP-ECPC event - A Europe of disparities - The role of the newly elected European Parliament in the fight against cancer

MEP Cristian Silviu BUSOI in hemicycle of Strasbourg during plenary session week 29 2014

Ramona Nicole MANESCU, Renate WEBER , Cristian Silviu BUSOI, Noriko NICOLAI and Adina-Ioana VALEAN

group photo of Romanian ALDE delegation

Cristian BUSOI MEP  in Plenary Session in Strasbourg

Audition de Michel BARNIER, commissaire désigné  au Marché intérieur et Services. IMCO. Hearing of Michel BARNIER, Commissioner-designate for Internal Market and Services

Cristian Silviu BUSOI at the EP in Brussels.

Members of the Committee on the Environment, Public Health and Food Safety (ENVI) exchange views with Margaritis SCHINAS, Vice-President of the European Commission in charge of promoting our European Way of Life on the 'lessons learnt' from the pandemic, in the European Parliament in Brussels.

Drawing the early lessons from the COVID-19 pandemic in ENVI Committee: Exchange of views

During the plenary session (7-10 June 2021) in the European Parliament in Strasbourg, MEPs debate on recent Cyberattacks on EU institutions and on sensitive national public and private institutions; and on the EU's Cybersecurity Strategy for the Digital Decade. Opening statements by by Ana Paula ZACARIAS, Secretary of State for European Affairs of Portugal, Council of the European Union and by Johannes HAHN, European Commissioner for Budget and Administration and by Cristian-Silviu BUŞOI (EPP,RO) author.

Joint debate on the cyberattacks in the EU: opening statements by by Ana Paula ZACARIAS, Council of the European Union, Johannes HAHN, European Commissioner for Budget and by Cristian-Silviu BUŞOI (EPP, RO) author

During the plenary session (7-10 June 2021) in the European Parliament in Strasbourg, MEPs debate on EU Digital COVID Certificate: MEPs debate 2/3

Joint debate on EU Digital COVID Certificate: MEPs debate 2/3

During the plenary session (7-10 June 2021) in the European Parliament in Strasbourg, MEPs debate on the state of the SMEs Union. MEPs debate part 1

Joint debate on the state of the SMEs Union: MEPs debate (part 1)

During the plenary session (26-29 April 2021) in the European Parliament in Brussels, MEPs debate on the Digital Europe programme.

Digital Europe programme: MEPs debate

During the plenary session (26-29 April 2021) in the European Parliament in Brussels, MEPs debate on European Defence Fund.

European Defence Fund: MEPs debate

During the plenary session (26-29 April 2021) in the European Parliament in Brussels, MEPs debate on the Digital green certificate - Union citizens & third countries - The accessibility and affordability of Covid-testing: MEPs debate part 1/3

Joint debate on the Digital green certificate - Union citizens & third countries - The accessibility and affordability of Covid-testing: MEPs debate part 1/3

During the plenary session (26-29 April 2021) in the European Parliament in Brussels, MEPs debate on research and innovation.

Joint debate - Research and Innovation: MEPs debate

Members of the Environment, Public Health and Food Safety (ENVI) Committee had an exchange of views on a new legislation for a faster authorisation procedure for COVID-19 vaccines that have already received EU authorisation, but which are being adapted to be effective against variants of the virus.

Quicker authorization procedure for adapted COVID-19 vaccines: exchange of views and statement by Cristian-Silviu BUŞOI (EPP, RO), Chair of the EP Committee on Industry, Research and Energy

During the plenary session of the European Parliament in Brussels (08-11 March 2021), MEPs debate on the programme for the Union's action in the field of health for the period 2021-2027 (“EU4Health Programme”): MEPs debate 1/3

Programme for the Union's action in the field of health for the period 2021-2027 (“EU4Health Programme”): MEPs debate 1/3

During the plenary session of the European Parliament in Brussels (08-11 March 2021), MEPs debate on the programme for the Union's action in the field of health for the period 2021-2027 (“EU4Health Programme”): Opening statement by Cristian-Silviu BUŞOI (PPE, RO), rapporteur, by Nicolae ŞTEFĂNUȚĂ (Renew, RO) BUDG and by Stella KYRIAKIDES, European Commissioner for Health and Food Safety. This transcription speech is the result of an automatic process. Check against delivery.

Programme for the Union's action in the field of health for the period 2021-2027 (“EU4Health Programme”): Opening statements

During the plenary session, MEPs debate and cast their final vote on the €5.1 billion EU4Health programme for 2021-2027. The programme aims to make EU health systems more resilient, address cross-border health threats and make medicines and medical devices more available, accessible and affordable. Statements by Stella KYRIAKIDES, European Commissioner for Health and Food Safety, Jytte GUTELAND (S&D, SE), Luisa REGIMENTI (ID, IT), Joanna Maria KOPCIŃSKA (ECR, PL), Frédérique RIES (Renew, BE), Marc BOTENGA (The Left, BE) and Cristian-Silviu BUŞOI (EPP, RO), Rapporteur.

EU4Health Programme: extracts from the debate and the vote and statement by Cristian-Silviu BUŞOI (EPP, RO)

Members of the Public Health (ENVI) and Industry (ITRE) committees debate how to increase capacity and improve delivery of COVID-19 vaccines with pharmaceutical companies (AstraZeneca, Moderna, CureVac, Novavax, Johnson & Johnson, Pfizer Group and Sanofi Pasteur) and Commissioners Thierry Breton and Stella Kyriakides. Statements of MEPs : CANFIN Pascal (Renew, FR), BUŞOI Cristian-Silviu (EPP, RO), GUTELAND Jytte (S&D, SE), BALDASSARRE Simona (ID, IT). Statements of CEOs of pharmaceutical companies : SORIOT Pascal, CEO AstraZeneca, BANCEL Stéphane, CEO Moderna, HAAS Franz-Werner, CEO Curevac, ERCK Stan, CEO Novavax, HWANG Angela, CEO Pfizer, STOFFELS Paul, CEO Johnson & Johnson, TRIOMPHE Thomas, CEO Sanofi.

How to increase the capacity of COVID 19 vaccine production and improve delivery: extracts from the Joint ENVI-ITRE hearing

Members of the Committee on the Environment, Public Health and Food Safety (ENVI) and the Committee on Industry, Research and Energy (ITRE) have a joint hearing on "How to increase the capacity of COVID 19 vaccine production and improve delivery". Exchange of views with CEOs of the pharmaceutical industry on COVID 19 (Corona) vaccine production and delivery. Welcome and opening remarks by Pascal CANFIN (Renew,FR), ENVI Chair, Cristian-Silviu BUŞOI (EPP,RO), ITRE Chair, Stella KYRIAKIDES, European Commissioner for Health and Food Safety.

Joint hearing of the ENVI and ITRE Committee "How to increase the capacity of COVID 19 vaccine production and improve delivery": Welcome and opening remarks

Statements by Pascal CANFIN (Renew, FR), ENVI chair, and by Cristian-Silviu BUŞOI (EPP, RO), ITRE Chair, following the exchange of views with CEOs of the pharmaceutical industry on COVID 19 vaccine production and delivery.

COVID 19 vaccine production and delivery: statements by Pascal CANFIN (Renew, FR) ENVI chair, and Cristian-Silviu BUŞOI (EPP, RO), ITRE Chair

Members of the Committee on the Environment, Public Health and Food Safety (ENVI) and the Committee on Industry, Research and Energy (ITRE) have a joint hearing on "How to increase the capacity of COVID 19 vaccine production and improve delivery". Exchange of views with CEOs of the pharmaceutical industry on COVID 19 (Corona) vaccine production and delivery. Closing remarks by Thierry BRETON, European Commissioner for Internal Market.

Joint ENVI - ITRE Hearing Joint hearing of the ENVI and ITRE Committee - "How to increase the capacity of COVID 19 vaccine production and improve delivery": Statement by Thierry BRETON, European Commissioner for Internal Market

Members of the Committee on the Environment, Public Health and Food Safety (ENVI) and the Committee on Industry, Research and Energy (ITRE) have a joint hearing on "How to increase the capacity of COVID 19 vaccine production and improve delivery". Session 1- Presentations by Pascal SORIOT, Chief Executive Officer, AstraZeneca, Stéphane BANCEL, Chief Executive Officer, Moderna, Franz-Werner HAAS, Chief Executive Officer, CureVac, accompanied by Antony BLANC, Chief Business Officer, Stan ERCK, President & Chief Executive Officer, Novavax.

Joint hearing of the ENVI and ITRE Committee - "How to increase the capacity of COVID 19 vaccine production and improve delivery": Session 1 - CEOs of the pharmaceutical industry

Members of the Committee on the Environment, Public Health and Food Safety (ENVI) and the Committee on Industry, Research and Energy (ITRE) have a joint hearing on "How to increase the capacity of COVID 19 vaccine production and improve delivery". Q&A with CEOs of the pharmaceutical industry Paul STOFFELS, Vice Chair of the Executive Committee and Chief Scientific Officer, Johnson & Johnson, Angela HWANG, President Global Biopharma, Pfizer Group, accompanied by Germain MORIN, VP Vaccines Supply Chain, Thomas TRIOMPHE, Executive Vice-President, Head of Sanofi Pasteur ,Suerie MOON, Co-Director, Global Health Centre, Graduate Institute of International and Development Studies, Geneva.

Joint hearing of the ENVI and ITRE Committee - "How to increase the capacity of COVID 19 vaccine production and improve delivery": Q&A with ENVI and ITRE Members and CEOs of the pharmaceutical industry

94 tulosta